AterianATER
ATER
About: Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Employees: 114
0
Funds holding %
of 7,139 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
713% more call options, than puts
Call options by funds: $610K | Put options by funds: $75K
0.06% less ownership
Funds ownership: 8.71% [Q3] → 8.65% (-0.06%) [Q4]
6% less funds holding
Funds holding: 31 [Q3] → 29 (-2) [Q4]
16% less capital invested
Capital invested by funds: $2.15M [Q3] → $1.82M (-$337K) [Q4]
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Research analyst outlook
We haven’t received any recent analyst ratings for ATER.
Financial journalist opinion
Neutral
GlobeNewsWire
2 days ago
Aterian Issues Letter to Shareholders
SUMMIT, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a technology-enabled consumer products company, today issued the following letter to shareholders from Arturo Rodriguez, Chief Executive Officer, and the Company's Board of Directors.
Neutral
Seeking Alpha
3 months ago
Aterian, Inc. (ATER) Q3 2024 Earnings Call Transcript
Aterian, Inc. (NASDAQ:ATER ) Q3 2024 Earnings Conference Call November 11, 2024 5:00 AM ET Company Participants Ilya Grozovsky - VP, IR & Corporate Development Arturo Rodriguez - CEO Josh Feldman - CFO Conference Call Participants Brian Kinstlinger - Alliance Global Partners Alex Furman - Craig Hallum Capital Group Marvin Fong - BTIG Operator Thank you for standing by. My name is Bella and I will be your conference operator today.
Neutral
GlobeNewsWire
3 months ago
Aterian Reports Third Quarter 2024 Results
Third Quarter Net Loss Improved by 71.7% Year Over Year Achieved Adjusted EBITDA Profit for the Second Consecutive Quarter, Marking a $4.9 Million Improvement Year-Over-Year SUMMIT, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the third quarter ended September 30, 2024.
Positive
Seeking Alpha
3 months ago
Aterian's Prospects Are Improving Under New Leadership - Buy
Aterian's changed leadership team has brought a new necessary refined approach. After a tumultuous few years, green shoots have appeared in recent financial results. The market price isn't fully accounting for Aterian's progress in the first half of the year, or its future prospects.
Neutral
GlobeNewsWire
3 months ago
Aterian Sets Date for Third Quarter 2024 Earnings Announcement & Investor Conference Call
SUMMIT, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its third quarter 2024 financial results after the market close on Monday, November 11, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.
Neutral
Seeking Alpha
6 months ago
Aterian, Inc. (ATER) Q2 2024 Earnings Call Transcript
Aterian, Inc. (NASDAQ:ATER ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, Investor Relations & Corporate Development Arturo Rodriguez - Chief Executive Officer Josh Feldman - Chief Financial Officer Conference Call Participants Brian Kinstlinger - Alliance Global Partners Alex Furman - Craig Hallum Capital Group Operator Thank you for standing by. My name is Kathy and I will be your conference operator today.
Neutral
GlobeNewsWire
6 months ago
Aterian Sets Date for Second Quarter 2024 Earnings Announcement & Investor Conference Call
SUMMIT, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2024 financial results after the market close on Thursday, August 8, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.
Positive
Seeking Alpha
7 months ago
Aterian: Cheap, But Speculative Turnaround Play - Upgrade To Buy
After the close of Wednesday's regular session, e-commerce brand consolidator Aterian raised Q2 expectations for botth the top- and bottom line. Following years of revenue declines and material cash burn, the company is finally showing signs of life. At the high-end of the increased range, the company would break-even on an Adjusted EBITDA basis for the first time since Q3/2021.
Neutral
GlobeNewsWire
7 months ago
Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges
Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Between a Loss of ($1.0) Million to $0.0 Million NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the appointment of Arturo (Arty) Rodriguez as Chief Executive Officer (previously the Company's Co-CEO and CFO) and Josh Feldman as Chief Financial Officer (previously the Company's SVP of Finance) and that Joe Risico has resigned as Co-CEO and from the Board of Directors and will consult the Company over a three month transition period. “On behalf of our Board of Directors, we express our deep gratitude for Joe's passion, innovative ideas, and relentless work ethic.
Neutral
Business Wire
8 months ago
Aterian Investment Partners Acquires Contract Pharmaceuticals Limited
NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. Based in Mississauga, Ontario, Canada, CPL is an industry leader with longstanding relationships with 15 of the top.
Charts implemented using Lightweight Charts™